CTA
CME icon

Chesley Taft & Associates’s CME Group CME Stock Holding History

Chesley Taft & Associates’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,348
Closed -$398K – 371
2026
Q1 		$398K Sell
1,348
-297
-18% -$88.2K 0.02% 297
2025
Q4 		$449K Sell
1,645
-43
-3% -$11.7K 0.02% 294
2025
Q3 		$456K Buy
1,688
+45
+3% +$12.2K 0.02% 275
2025
Q2 		$453K Sell
1,643
-58
-3% -$15.8K 0.02% 265
2025
Q1 		$451K Buy
1,701
+263
+18% +$64.9K 0.02% 260
2024
Q4 		$334K Sell
1,438
-45
-3% -$10.3K 0.02% 282
2024
Q3 		$327K Sell
1,483
-212
-13% -$43.9K 0.02% 281
2024
Q2 		$333K Sell
1,695
-75
-4% -$15.5K 0.02% 276
2024
Q1 		$381K Sell
1,770
-200
-10% -$42K 0.02% 268
2023
Q4 		$415K Hold
1,970
– – 0.02% 255
2023
Q3 		$394K Sell
1,970
-159
-7% -$31.6K 0.03% 243
2023
Q2 		$394K Sell
2,129
-70
-3% -$12.9K 0.02% 244
2023
Q1 		$421K Sell
2,199
-79
-3% -$14.3K 0.03% 234
2022
Q4 		$383K Hold
2,278
– – 0.03% 238
2022
Q3 		$404K Hold
2,278
– – 0.03% 227
2022
Q2 		$466K Hold
2,278
– – 0.03% 228
2022
Q1 		$538K Buy
2,278
+130
+6% +$30.5K 0.03% 227
2021
Q4 		$491K Sell
2,148
-95
-4% -$20.9K 0.03% 238
2021
Q3 		$434K Sell
2,243
-270
-11% -$54.7K 0.02% 243
2021
Q2 		$534K Hold
2,513
– – 0.03% 226
2021
Q1 		$521K Sell
2,513
-67
-3% -$13.2K 0.03% 219
2020
Q4 		$470K Hold
2,580
– – 0.03% 220
2020
Q3 		$432K Sell
2,580
-120
-4% -$20.2K 0.03% 206
2020
Q2 		$439K Sell
2,700
-100
-4% -$17.9K 0.03% 199
2020
Q1 		$484K Hold
2,800
– – 0.04% 187
2019
Q4 		$562K Hold
2,800
– – 0.04% 201
2019
Q3 		$592K Sell
2,800
-500
-15% -$104K 0.05% 194
2019
Q2 		$641K Hold
3,300
– – 0.05% 187
2019
Q1 		$543K Hold
3,300
– – 0.05% 202
2018
Q4 		$621K Hold
3,300
– – 0.06% 188
2018
Q3 		$562K Sell
3,300
-370
-10% -$62.3K 0.04% 209
2018
Q2 		$602K Buy
3,670
+100
+3% +$16.3K 0.05% 204
2018
Q1 		$577K Hold
3,570
– – 0.05% 207
2017
Q4 		$521K Hold
3,570
– – 0.04% 221
2017
Q3 		$484K Sell
3,570
-125
-3% -$15.8K 0.04% 221
2017
Q2 		$463K Sell
3,695
-200
-5% -$23.9K 0.04% 221
2017
Q1 		$463K Hold
3,895
– – 0.04% 220
2016
Q4 		$449K Sell
3,895
-200
-5% -$22.3K 0.04% 221
2016
Q3 		$428K Sell
4,095
-300
-7% -$31.3K 0.04% 210
2016
Q2 		$428K Hold
4,395
– – 0.04% 211
2016
Q1 		$422K Hold
4,395
– – 0.04% 205
2015
Q4 		$398K Hold
4,395
– – 0.04% 209
2015
Q3 		$408K Buy
+4,395
New +$418K 0.04% 187

Other funds holding CME

PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Chesley Taft & Associates's CME Position: Q2 2026 in Review

Chesley Taft & Associates sold out of CME Group (CME) in Q2 2026, closing a stake of 1,348 shares — an estimated $398K sold.

Chesley Taft & Associates first reported a position in CME in Q3 2015 and held it in 43 quarters. The position peaked at $641K in Q2 2019. 333 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Chesley Taft & Associates reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Chesley Taft & Associates sold 1,348 CME Group shares in Q2 2026, an estimated $398K.
  • Chesley Taft & Associates first reported a position in CME Group in Q3 2015 and held it in 43 quarters.
  • Chesley Taft & Associates's CME Group position peaked at $641K in Q2 2019.
  • 333 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.